Dr. Yi-Yen Chen

Dr. Yi-Yen Chen has over 9 years of healthcare-related experience. Currently, she is responsible for US healthcare investment and portfolio management at WI Harper. Prior to joining the Healthcare Investment Team, she worked in business development and drug licensing at Microbio Group in Taiwan. Dr. Chen was the R&D project head and led the development of the world’s biggest antibody portfolio for the zebrafish research community at GeneTex.

She completed her PhD in developmental biology from Nobel Laureate Professor Christiane Nüsslein-Volhard’s lab at the Max-Planck Institute in Germany. Her postdoctoral training was in molecular biology at the Institute of Molecular Biology in Mainz, Germany, and in cancer immunotherapy at the Netherlands Cancer Institute in Amsterdam.